Nomura Asset Management CO LTD Pliant Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$10.52 - $14.35 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$10.58 - $15.61 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$14.14 - $19.59 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$12.85 - $19.15 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$14.58 - $20.15 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$18.12 - $30.56 $0 - $0
0 New
0 $0

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email